Nuo Therapeutics (AURX) EBT Margin (2009 - 2026)
Nuo Therapeutics (AURX) reported EBT Margin of -9.42% for Q2 2026, up 83.70 percentage points from -93.12% a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Nuo Therapeutics' EBT Margin came in at -42.15%, up 91.35 percentage points year-over-year; for FY2025, it came in at -75.82%, up 94.40 percentage points from FY2024.
- EBT Margin has increased for three consecutive years, with a three-year change of +2749.78 percentage points (FY2022 to FY2025).
- By year, EBT Margin came in at -170.21% in FY2024 (+350.95 pp), -521.17% in FY2023 (+2304.43 pp) and -2825.60% in FY2022.
- The Q2 2026 figure ranks as the highest quarterly EBT Margin since Q4 2019.
- Across the past five years, year-over-year gain in EBT Margin ran from 55.46 percentage points in Q2 2025 to 2043.99 percentage points in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 17.20% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 9.46% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 17.27% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 21.92% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 18.13% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | 15.29% |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 14.27% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 21.17% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 4.91% |
| 10 | Nuo Therapeutics | 51.81 Mn | 50.03 Mn | 1.17 Mn | -9.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.42% |
| Mar 31, 2026 | -34.29% |
| Dec 31, 2025 | -52.82% |
| Sep 30, 2025 | -52.33% |
| Jun 30, 2025 | -93.12% |
| Mar 31, 2025 | -153.83% |
| Dec 31, 2024 | -159.35% |
| Sep 30, 2024 | -155.65% |
| Jun 30, 2024 | -148.58% |
| Mar 31, 2024 | -302.35% |
| Dec 31, 2023 | -330.99% |
| Sep 30, 2023 | -339.97% |
| Jun 30, 2023 | -737.44% |
| Mar 31, 2023 | -1,399.66% |
| Dec 31, 2022 | -1,301.60% |
| Sep 30, 2022 | -2,383.96% |
| Dec 31, 2019 | 1,505.55% |
| Sep 30, 2019 | -66.85% |
| Jun 30, 2019 | -888.59% |
| Mar 31, 2019 | -1,559.64% |
API Access
Nuo Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();